rs776977023
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_006623.4(PHGDH):c.505A>G(p.Met169Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000697 in 1,435,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M169L) has been classified as Uncertain significance.
Frequency
Consequence
NM_006623.4 missense
Scores
Clinical Significance
Conservation
Publications
- neurometabolic disorder due to serine deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- PHGDH deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
- Neu-Laxova syndrome 1Inheritance: AR Classification: MODERATE Submitted by: G2P
- Neu-Laxova syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.97e-7 AC: 1AN: 1435384Hom.: 0 Cov.: 25 AF XY: 0.00000140 AC XY: 1AN XY: 715698 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at